Oral Cancer Products

DOE Dental Oral Exam System

DentLight’s DOE is a dental oral exam system that uses patentpending collimated, high-power LED Beam technology for nonrinse magnified fluorescence imaging of oral tissue and teeth.

Identafi Oral Cancer Screening Device

Identafi Oral Cancer Screening Device

DentalEZ Group

Identafi uses 3 different wavelengths to enhance the visualization of mucosal abnormalities.

The Identafi oral cancer screening device was recently acquired by DentalEZ Group. The device features fluorescence and reflectance technology with 3 unique wavelengths and helps the dental professional combine enhanced visual examination with conventional tactile examination to provide a high standard of care, according to DentalEZ.

Microlux/DL

AdDent’s Microlux/DL diffused illuminator is designed to enhance dental examinations of oral mucosa and aid in the identification of abnormal lesions found on the soft tissues of the mouth.

OralCDx Brush Test

From OralCDx Labs, the OralCDx Brust Test is a computer-assisted brush biopsy test that can determine if oral lesions contain potentially dangerous precancerous or cancerous cells.

OraRisk HPV Salivary Diagnostic Test

OraRisk HPV Salivary Diagnostic Test

OralDNA Labs

The OraRisk HPV test is a noninvasive, easy-to-use screening tool to identify oral HPV.

OraRisk HPV from OralDNA Labs provides the clinician with the ability to establish risk for HPV-related cancers of the oral, head, and neck regions and determine appropriate referral and monitoring conditions. Early detection of oral HPV presents an important opportunity to detect those at risk for these types of cancers before symptoms appear.

Sapphire Plus Lesion Detection

The Sapphire Plus Lesion Detection from DenMat provides clinicians with enhanced visual information to detect and diagnose the presence of cancer or precancer.

VELscope

Oral Cancer Screening System

VELscope is designed to be an adjunct to traditional oral cancer examination procedures.

According to the manufacturer, VELscope technology is based in part on the direct visualization of tissue fluorescence and the changes in fluorescence that occur when abnormalities are present. It was developed in collaboration with the British Columbia Cancer Agency with significant funding from the National Institutes of Health.

ViziLite Plus with TBlue

Oral Lesion Identification and Marking System

Oral cancer is 90% curable when found early, but 70% of oral cancers are diagnosed in the late stages.

ViziLite Plus with TBlue is an oral lesion identification and marking system that is used as an adjunct to the conventional head and neck examination. The product includes an acetic acid rinse, a chemiluminescent light source, and a blue phenothiazine dye to mark lesions identified by the light. According to the manufacturer, ViziLite Plus is designed to be used in a patient population at increased risk for oral cancer.